Regenxbio (RGNX) Invested Capital (2014 - 2025)

Regenxbio's Invested Capital history runs 12 years deep, the most recent figure standing at $102.7 million for Q4 2025.

• In Q4 2025, Invested Capital fell 60.43% year-over-year to $102.7 million; the TTM figure through Dec 2025 stood at $102.7 million (down 60.43% YoY), while the FY2025 annual figure was $102.7 million, down 60.43% from the prior year.
• Invested Capital was $102.7 million for Q4 2025 at Regenxbio, down from $161.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $764.3 million in Q4 2021 to a low of $102.7 million in Q4 2025.
• Historically, Invested Capital has averaged $414.3 million across 5 years, with a median of $398.3 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Invested Capital soared 102.33% in 2021, then slumped 60.43% in 2025.
• A 5-year view of Invested Capital shows it stood at $764.3 million in 2021, then tumbled by 32.46% to $516.2 million in 2022, then sank by 39.61% to $311.7 million in 2023, then fell by 16.71% to $259.7 million in 2024, then plunged by 60.43% to $102.7 million in 2025.
• The last three Invested Capital figures came in at $102.7 million (Q4 2025), $161.5 million (Q3 2025), and $213.7 million (Q2 2025), per Business Quant data.